|
Orthologous residues
|
|
GluR4 (human): S862‑p, GluR4 iso2 (human): ‑, GluR4 (mouse): S862‑p, GluR4 iso2 (mouse): S862‑p, GluR4 (rat): S862‑p
|
|
Characterization
|
|
Methods used to characterize site in vivo:
phospho-antibody, western blotting
|
|
Relevant cell lines - cell types - tissues:
'brain, hippocampus', 293 (epithelial), retina
|
|
Cellular systems studied:
cell lines, primary cells, tissue
|
|
Species studied:
chicken, human, rat
|
|
Upstream Regulation
|
|
Potential in vivo enzymes for site:
|
|
Type
|
Enzyme
|
Evidence
|
Notes
|
|
KINASE
|
PKACa (human)
|
phospho-antibody, pharmacological activator of upstream enzyme
|
|
|
KINASE
|
PKCG (human)
|
phospho-antibody, mutation in upstream enzyme recognition motif, co-immunoprecipitation, pharmacological activator of upstream enzyme, transfection of wild-type enzyme
|
|
|
|
Treatments, proteins and their effect on site modification:
|
|
Treatments
|
Referenced Treatments
|
Manipulated Protein
|
Referenced Protein
|
Effect
|
Notes
|
|
phorbol ester
|
|
|
|
increase
|
|
|
forskolin
|
|
|
|
increase
|
|
|
|
|